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Abstract
Aim: To highlight the changes that may take place in
the visual system of the class A drug abuser.
Methods: A literature review was carried out of
ocular/visual sequelae of the more common class A
drugs. These include stimulants (cocaine and crack
cocaine), narcotics (heroin, morphine, methadone)
and hallucinogenics (ecstasy, lysergic acid diethyl-
amide, magic mushrooms, mescaline, phencyclidine).
Results: Ocular sequelae affecting visual acuity, the
eye and its adnexa, ocular posture and ocular motility
can result from recreational use of these drug(s).
Conclusions: Awareness of the consequences of illicit
drug use should lead to more pertinent questioning
during history-taking.
Key words: Cocaine and crack cocaine, Heroin, LSD,
MDMA (ecstasy), Mescaline, Ocular motility disorders,
Phencyclidine, Psilocybin and psilocin (magic mush-
rooms), Vision disorders
Introduction
This review highlights the changes that may take place
in the visual system of the drug abuser and thus may help
to alert the clinician to clinical presentations that may be
the result of illicit drug use. Awareness of these condi-
tions should lead to more pertinent questioning during
history-taking.
The review contains many individual case reports,
indicating the rarity of some of the sequelae encoun-
tered. However, larger case series or original research
articles are also included.
The main and more serious ophthalmological compli-
cations arise from the use of cocaine/crack cocaine,
ecstasy (methylenedioxymethamphetamine: MDMA) or
heroin (diamorphine). However, other narcotics and
hallucinogenics are included for the sake of complete-
ness. Class B drugs when prepared for injection become
class A but these are not included in this review (Table
1). Whilst the effects are discussed under each individual
drug there is overlap as polydrug use is common.
Stimulants
Cocaine and crack cocaine
Cocaine hydrochloride is a fine crystalline powder that is
usually sniffed. If converted into its base form, the pure
cocaine is known as ‘crack’ due to the crackling noise it
makes when smoked. Cocaine acts as a sympathomi-
metic and has vasoactive properties. The sympathomi-
metic effect (cocaine prevents the reuptake of
norepinephrine) leads to dilated pupils. Mitchell and
Schwartz1 report a 55-year-old man who presented with
right eye pain and blurred vision which was diagnosed as
acute angle closure glaucoma. Three days later a
recurrence of the angle closure occurred and the patient
admitted intranasal cocaine use through his right nostril.
The authors suggest that either transmucosal absorption
of the cocaine or a retrograde nasal delivery through the
nasolacrimal duct may have been the mechanism, or that
topical application from rubbing the eye may have
occurred.
In high concentration cocaine may cause exophthal-
mos, retraction of the upper lid and cycloplegia. In a
series of 216 patients who presented to a medical
emergency department Brody et al.2 found 6 who
complained of blurred vision. This was felt likely to be
due to sympathetic stimulation, but further investigation
to determine the cause was not reported.
Phenytoin may be added to crack cocaine. This may
lead to phenytoin toxicity effects, which include
nystagmus, when the crack is smoked.3,4
Cerebrovascular disease: ocular motility and retinal
problems
Neurological complications include cerebrovascular
disease, more frequently haemorrhagic than ischaemic.5
This may either lead to defects in eye movements or
affect visual acuity. A midbrain haemorrhage which
Table 1. British classification of drugs of abuse
Class A Class B Class C
Cocaine Amphetamines Anabolic steroids
Crack cocaine Barbiturates Cannabis/marijuana
Ecstasy Codeine Mild amphetamines (e.g.
temazepam, valium)
Heroin DF118 (mild
opiate)
Lysergic acid
diethylamide
Magic mushrooms
Mescaline
Methadone
Phencyclidine (PCP)
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resulted in bilateral internuclear ophthalmoplegia (INO),
bilateral ptosis, limited upgaze with convergence-retrac-
tion nystagmus, and 4 mm pupils which were unreactive
to light but responded normally on accommodation has
been reported in a 35-year-old man.6 The onset occurred
a few hours after smoking several vials of crack cocaine
and was accompanied by vertigo and incoordination of
his right limbs. General examination was unremarkable
and visual acuity and fields were within normal limits.
Computed tomography showed a haemorrhage in the
midbrain tegmentum which had fully resolved on repeat
scan 2 months later. At this time all signs had resolved
except for limitation of upgaze. The authors suggest that
the haemorrhage was due to rupture of a cryptic
arteriovenous malformation precipitated by the elevation
in blood pressure due to the sympathomimetic action of
cocaine. A further three cases of presumed stroke
resulting in unilateral INO, bilateral INO and trochlear
nerve palsy secondary to use of crack cocaine have been
reported.7
Orbital infarction has been reported in a 36-year-old
woman who had inhaled cocaine and heroin and lost
consciousness with her head down and the left side of
her face and orbit pressed against a desk.8 Magnetic
resonance imaging revealed diffuse swelling of the
extraocular muscles but magnetic resonance angiogra-
phy and venography were normal. Complete left ptosis,
with severe limitations of ductions of the left eye in all
positions of gaze was present. There was no perception
of light by the left eye and right visual acuity was 6/6. A
relative afferent pupillary defect was present in the left
eye but the pupil reacted normally to consensual
stimulation. The left fundus showed residual retinal
oedema and retinal pigment epithelium disruption
throughout, with markedly attenuated arterioles. No
other abnormalities were detected and laboratory tests
were normal. After 1 month there was a slight
improvement in only the ptosis and eye movements.
Although compression alone may cause orbital infarc-
tion (defined as ischaemia of all intraocular and orbital
structures), the authors felt that the increase in
sympathetic tone along with vasospasm from the cocaine
use was a contributory factor.
Transient loss of monocular vision (episodes lasting 1
minute) has been reported in an intranasal cocaine
abuser.9 Retinal vasospasm was thought to be the most
likely cause. Loss of vision lasting for longer periods or
persisting, appears to be more frequent.10–15 Patients
may present with markedly reduced vision in both eyes.
Vasospasm or an obstruction caused by fibrinoid
necrosis within the vessel or atherosclerotic plaques
due to hypertensive effects are thought to be the cause.
Recovery of visual acuity is variable.
Cocaine-induced cerebral vasculitis may also be the
mechanism in some visual effects. Transient blurring of
vision was reported as one sign in an intranasal cocaine
user who later, following a generalised tonic seizure, had
a left gaze palsy.16 Cerebral angiography showed
findings consistent with vasculitis. Krendel et al.17
report 2 cases of vasculitis confirmed by biopsy; one
patient had bilateral blindness and the other (who later
died) had bilateral papilloedema due to cerebral oedema.
Such cases present with other symptoms that may
include weakness of one side of the body, headache,
slurred speech, confusion and hemianaesthesia.
Microtalc retinopathy with associated retinal nerve
fibre layer ‘rake’ or ‘slit’ defects has been observed by
Rofsky et al.18 in ‘approximately 60 cases’ where
patients had a history of smoking crack cocaine. Three
cases are reported in detail, each with acuity of 20/20
either eye. Some patients showed visual field changes
which had the appearance of glaucoma-like defects,
being inferior nasal steps. The authors suggest that the
microtalc dusting of the retina is probably due to very
small crystalline deposits from the adulterants of the
crack which have become lodged in the inner retinal
layers or the retinal circulation. The preference for the
superior portions of the optic nerve head is not explained
but likened to anterior ischaemic neuropathy, where the
field loss is most commonly inferior altitudinal.
Endophthalmitis
Endogenous endophthalmitis has been reported in one
cocaine addict who injected cocaine intravenously.19
This 22-year-old presented complaining of severe pain in
the right eye accompanied by loss of vision and watering
of the eye. A Bacillus species (later identified as Bacillus
cereus) was grown from blood culture; this is a
bacterium found in air, water, soil or dust and was
thought to have been introduced from the injection
leading to blood-borne endophthalmitis. Despite treat-
ment with local and systemic antibiotics acuity was not
saved and follow-up showed a phthisical eye.
Myasthenia gravis
Another aetiology for ocular motility problems from
cocaine use is the unmasking or exacerbation of
myasthenia gravis. Berciano et al.20 report a 24-year-
old woman who had general signs of myasthenia,
including diplopia, immediately after sniffing cocaine.
The signs lasted for about 15 minutes but a few months
later generalised signs occurred again which were
exacerbated by cocaine. This led the patient to stop
using cocaine; however, myasthenia gravis still devel-
oped. In another case, a polydrug user presented to
hospital because of abscesses from injecting but also
complained of generalised weakness, dysphagia and
bilateral ptosis. The 29-year-old woman was using 2 g
cocaine daily as well as 1 g heroin and 40 mg
methadone.21 Ophthalmological examination 6 days
following the last use of cocaine or heroin revealed
bilateral ptosis, left greater than right (palpebral fissures
6.5 mm and 3.5 mm respectively), complete bilateral
external ophthalmoplegia with the eyes fixed in down-
gaze and exotropia of approximately 10°. No eye
movements could be elicited by Bell’s phenomenon,
vestibulo-ocular reflex or optokinetic testing. The pupils
barely reacted to light but reacted on accommodation
and constricted with 0.1% pilocarpine, confirming a
‘pseudotonic’ pupil. Neurological investigations were
normal (including magnetic resonance imaging) and
edrophonium test was positive. Ocular motility and
pupillary reactions returned to normal with medication
(pyridostigmine 180 mg daily) and remained so with
further use of cocaine, heroin and methadone. The
authors suggest that the cocaine blocks the sodium
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channels and causes a slowing in presynaptic neuronal
transmission. Daras et al.22 report a 33-year-old
myasthenic man who had eight hospital admissions
during a 13 month period: three related to non-compli-
ance with medication and 5 within 24 hours of intranasal
cocaine use. Diplopia is listed amongst the symptoms
that occurred during these exacerbations.
Destruction of bony tissue
The destruction of the nasal septum due to intranasal
cocaine use has been given press coverage in recent
times. Intense vasoconstriction and anaesthesia is
induced and this leads to mucoperichondrial ischaemia.
However, the destruction may extend to the bony walls
of the orbit, which can lead to nasolacrimal duct obstruc-
tion due to inflammation and orbital cellulitis.23,24
Common presenting features in a series of 7 patients
were epiphora, periorbital pain, oedema, and erythema
associated with fever.23 The authors emphasise the
importance of anterior rhinoscopy in correct diagnosis of
the cause in this group of patients. Underdahl et al.24
suggest that the destruction may be exacerbated by
microvascular changes from diabetes mellitus and report
a 40-year-old man with medial wall destruction and
preseptal cellulitis.
The loss of the bony structures around the optic nerve
and chronic inflammation in the sinuses have been
postulated to be the cause of optic neuropathy in cocaine
users25,26 and the development of a pneumocoele
secondary to nasal obstruction has been reported.27
Corneal problems
Several single cases have been reported where the use of
crack cocaine has affected the cornea.13,28–31 A series of
12 patients32 illustrates the various corneal problems that
may occur, including corneal ulcers, superficial punctate
keratitis and corneal epithelial defects. The presentation
in these patients tended to be either a relatively painless
loss of vision, redness and purulent discharge associated
with infectious corneal ulceration or painful loss of
vision, redness, photophobia and tearing. The latter was
associated with sterile epithelial defects after eye
rubbing. Five of 10 patients tested showed reduced
corneal sensitivity. No corneal perforations occurred. In
some patients microbial (e.g. Staphylococcus epidermi-
dis, Streptococcus pneumoniae) or fungal (e.g Candida
albicans) organisms were identified. Various sugges-
tions are made regarding the mechanism: direct toxic
effect from the smoke; decreased corneal sensitivity
resulting in reduced blinking and exposure keratopathy;
neurotrophic changes; subclinical alkali burn from the
smoke; eye irritation leading to vigorous rubbing. A
single case report suggesting an increased risk of
microbial keratitis in cocaine abusers who wear soft
contact lenses has been reported.33 The 23-year-old
woman accidently administered cocaine powder to her
left eye which she then rubbed. On examination the
following day, a corneal ulcer 3.5 mm by 4 mm was
seen. The authors suggest that the direct toxic effect of
the cocaine on the cornea combined with vigorous
rubbing increased the risk of infection in a patient whose
wearing of soft weekly disposable contact lenses had
already placed her in a higher-risk group.
One 32-year-old patient instilled cocaine into her
conjunctival fornix, rather than sniffing it, and developed
corneal ulcers bilaterally with Staphylococcus aureus
infection. Extensive scarring resulted and final acuities
were 20/70 in her right eye and light perception in her
left. The left eye was enucleated 4 months later due to
high intraocular pressure and severe pain.34
One patient had floppy eyelids and papillary con-
junctivitis. It was suggested that these conditions
contribute to the formation of corneal ulcers.35
Injury from self-abuse
After use of marijuana, amphetamines and cocaine one
25-year-old felt he could only ‘get oxygen’ by pushing a
signet ring into his eye. On presentation there was
periorbital oedema and severe conjunctival swelling.
Skull radiograph and CT scan revealed the ring in the
maxillary antrum, with possible fracture of the roof,
haemorrhaging, surgical emphysema and enophthalmos.
The ring was removed via the Caldwell-Luc approach
but vision was lost.36
Madarosis
Smoking crack cocaine from a glass tube resulted in
bilateral loss of the eyebrows and eyelashes due to
singing. The hair grew back once the 17-year-old
abstained from smoking.37
Sequelae from prenatal exposure
Chiriboga et al.38 studied 30 babies who had been
exposed prenatally to cocaine and concluded that this
was associated with tone and movement disorders.
Neurological abnormalities included hypertonia, plantar
extension and coarse tremor. Smaller head size was also
found in the cocaine-exposed group. Two babies showed
persistent tonic downgaze, which resembled the setting
sun sign, but was overcome by head movements. The
duration of the sign reduced from about 75% of the time
to 66% of the time over a 3 week period; however, one
baby examined at age 6 months still demonstrated ‘rare
and brief tonic downward gaze’.
Four cases of congenital exotropia in drug-exposed
babies led Dominguez et al.39 to further identify 6 other
cases with developmental delay and congenital cerebral
anomalies where prenatal drug exposure was present. In
7 the drug was cocaine, and in the remaining 3 it was
heroin, amphetamines or phenylpropanolamine (diet
pills). Nine of the 10 babies had ophthalmological
abnormalities including 5 with exotropia (one with
nystagmus in addition), 2 with esotropia, 1 with absent
upgaze, and 1 with unilateral 3rd nerve palsy and
nystagmus (diet pills). Two of these 9 also had
hypoplastic or atrophic optic discs (1 cocaine-exposed,
1 amphetamine-exposed). All babies showed global or
motor delay and congenital malformations of the brain
on neuroimaging. These authors estimate that 0.8–1.2%
of infants with prenatal drug exposure have congenital
malformations of the brain. The mechanisms for these
defects are poorly understood but could be due to
vasoconstriction causing diminished fetal perfusion or
effects on the central nervous system due to a direct
effect on the brain related to the dopaminergic sytem.38
Hand et al.40 found no difference in the incidence of
12 A. Y. Firth
Br Ir Orthopt J 2004; 1
retinopathy of prematurity in very low birth weight
infants who had been cocaine-exposed compared with
those who had not.
Isenberg et al.41 reported that slit lamp examination of
13 cocaine-intoxicated neonates showed that most had
iris blood vessel abnormalities. Five were followed up
and they showed gradual resolution without any apparent
long-term visual sequelae.
Changes in eye movement systems
No differences have been found in saccadic velocity,
amplitude or duration between cocaine-abusers and non-
drug-users,42 nor in smooth pursuit, optokinetic nystag-
mus, vestibulo-ocular reflex, visual suppression of the
vestibulo-ocular reflex, or caloric testing.43 Tracking
accuracy, however, has been reported as superior to that
of non-drug-users due to a small increase in eye
movements at target frequency.44 Attention fixations
and antisaccades have been examined with relation to
craving and foraging for cocaine.45,46 An inverse
correlation was found between cocaine craving scores
and the number of pre-attentive fixations.
Electroretinogram changes
The dopamine-altering effect of cocaine, which leads to
increased dopaminergic neurotransmission, led Roy et
al.47 to hypothesise that cocaine-dependent subjects
would show abnormalities in electroretinogram (ERG)
recordings. Twenty subjects admitted to a rehabilitation
unit were tested, all of whom had been drug-free for a
minimum of 3 days prior to the test. None were
dependent on opiates, barbiturates, alcohol or marijuana.
Cone ERGs to a white flash were not different between
normals and the patient group; however, blue cone ERG
showed significant reduction, the mean amplitude being
about half that of the normal subjects. The changes
identified persisted for at least 8 weeks without
regression.48 Further, this reduction has been found to
relate to cocaine craving, such that the ERG could be an
indicator of subjects more vulnerable to future re-
lapse.49,50
Defects in colour vision
As dopamine plays a role in colour vision Desai et al.51
investigated colour vision using the Farnswell-Munsell
100-hue and Lathony desaturated D-15 colour vision
tests. Thirty-one inpatients who had recently stopped
using cocaine were tested and compared with a control
group matched for age and gender. The cocaine-
withdrawn group showed a significantly higher error
score on both tests, with 23 and 15 showing blue–yellow
vision loss on the Farnswell-Munsell 100-hue and
Lathony desaturated D-15 test, respectively. There were
no significant differences for either red–green or mixed
colour deficiencies. The authors consider the impairment
due to the effect of cocaine on retinal neural transmis-
sion, and dismiss the possibility that vasoconstrictive
effects on the retina are responsible, as no patient
showed any evidence of retinal lesions.
Narcotics
Heroin (diamorphine), morphine, methadone
The main abuse with this group of opiates occurs with
heroin and methadone. Although heroin can be sniffed or
taken orally, it is usually smoked or injected. The effects
of heroin are feelings of euphoria, peace and freedom
from fear. It is a powerful analgesic. One sign of opiate
use is miosis.52 There has been some dispute as to
whether tolerance develops, as pupils are still found to
be miosed in long-term addicts; however, Tress and El-
Sobky53 found that to produce the same amount of
constriction a much lower dose was necessary in non-
dependent subjects than dependent subjects. Pupillary
dilation has been shown to last for 5 days following
withdrawal of heroin54 and anisocoria may occur in
some subjects (18% compared with 4% in the control
group), usually during the first or second day of
withdrawal.55 In a systematic study of the effect of
daily methadone use (50–60 mg) on pupil size under
different light intensities, Weinhold and Bigelow56
found that peak miosis was 90 minutes after methadone
administration and was best detected under moderately
dim lighting conditions.
Visual acuity loss
Buyers will often taste the heroin, which is bitter, to test
quality. Quinine is sometimes used as a cutting agent,
because of its bitter taste, to disguise dilute heroin. Toxic
amblyopia due to quinine may occur.57–60 Brust and
Richter57 report a patient taking about 5 g of quinine per
day. Whilst vision did improve from the initial RE: hand
movements and LE: 5/200 when on heroin without
quinine, it deteriorated when the patient started using a
heroin supply with quinine again. Pruzon et al.60 found
positive Amsler chart results in 3 of 14 addicts with
blurred vision.
Quinine causing temporary visual loss was reported in
another heroin user,58 who started on a home-based
detoxification programme and took quinine to help with
muscle cramps. On presentation (after taking 206 g
quinine sulfate tablets over a 12 hour period) acuities
were limited to light perception; fundal examination
showed attenuation of retinal arterioles and pallor. Eight
days later acuities were 6/6 in either eye.
With overdose, respiratory function is depressed and
one case of delayed postanoxic encephalopathy is
reported where death eventually occurred.61 However,
prior to this pupils were reactive but visual acuity was
limited to perception of large images. Optic discs were
normal in appearance and presumably the visual defect
was cortical.
Endophthalmitis
Metastatic endophthalmitis, due to Candida albicans,
may occur where lemon juice has been used to dissolve
the heroin and injected; or some cutting agents may
embolize to the eye.62 Martinez-Vazquez et al.63 report a
series of 15 cases, 12 with severe vitritis and 3 with
uveitis. Seven patients underwent early vitrectomy and
all had favourable responses. Late vitrectomy or no
vitrectomy led to blindness in most cases. The authors
concluded that early vitrectomy preceded and followed
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by antifungal therapy should be the treatment method.
Candidiasis may affect several parts of the body. Of 9
young men who used the same heroin, 7 (the other 2
having boiled the heroin preparation before injection)
presented with hepatitis, followed by skin lesions,
osteomyelitis, costochondritis (pain and tenderness in
costal cartilage) and ocular lesions (chorioretinitis in 5
and episcleritis in 2).64 Whilst no comment is made on
the mechanism in this series, Hoy and Speed65 report 8
cases over 4 years of candidiasis, in which 5 had ocular
involvement (chorioretinitis and/or episcleritis). All had
used lemon juice and at least 5 used a lemon which had
been cut open more than 24 hours previously. The
interior of lemons can support Candida albicans growth.
Intralenticular abscess may also develop.66 Another
cause of metastatic endophthalmitis in drug users has
been identified as Aspergillus (an air-borne fungus).67
Strabismus and ocular motility disorders
Himmelsbach in 194168 stated that patients, when with-
drawing from heroin, sometimes complain of double
vision or some impairment of vision. The incidence of
‘diplopia/blurred vision’ during both previous and
current attempts at withdrawal in US soldiers who had
served in Viet Nam69 was found to be between 10% and
33.3% depending on the mode of heroin use.
Small case series of esotropia following heroin detoxi-
fication have appeared in the recent literature70–72 and
diplopia, in the absence of extraocular paresis, has been
associated with the use of chlorpromazine (Largactil)
during withdrawal in one patient.73 Exotropia has been
reported on intake of heroin in 2 cases.72
In a prospective study of patients attending a detoxi-
fication programme Firth et al.74 reported a significant
change in horizontal angle of deviation at distance,
demonstrating a change in the eso direction (median 6)
with about one-third of patients complaining of diplopia
immediately post-detoxification. No statistical differ-
ence existed in the total prism fusion range before and
after detoxification for near or distance and sixth nerve
involvement was not implicated. Stereo-acuity, visual
acuity (near; distance; reduced contrast) and conver-
gence were found to be reduced in the immediate post-
detoxification period. Subjective accommodation did not
reduce but a small decline was found in objective
accommodation at 20 cm. No changes in refractive error
or objective accommodation at 33 cm were found.
Further, no difference was found in the accommodation
of the heroin users and a control group. Contrary to this
Perez et al.75 reported decreased or abnormal accom-
modation in 10 of 15 heroin users; however, the
mechanism is suggested to be due to the sympathomi-
metic effect of cocaine, as 12 of the 15 subjects also used
cocaine.
Wound botulism has been reported in 2 intravenous
heroin users.76,77 Diplopia, dysphagia, dysphonia and
descending paralysis occur. Effects are reversed with
anti-toxin administration.
Cases of internuclear ophthalmoplegia following
opiate overdose have been reported.78,79 Rizzo and
Corbett80 report one case of bilateral internuclear
ophthalmoplegia in a known polydrug user (currently
using methadone, diazepam, propoxyphene, and pheny-
toin sodium irregularly for generalized seizures co-
incident with the multiple drug use). On presentation
there was a decreased level of responsiveness; he was
complaining of headaches, blurred vision and lethargy.
Ecchymosis was present from a punch to the left eye 2
weeks earlier, and the eyes appeared exotropic. Limita-
tion of both eyes on adduction with nystagmus of the
abducting eye was present; convergence was normal.
Speech was slurred. Naloxone (narcotic antagonist) was
administered and within 5 minutes the patient was alert
and eye movements returned to normal. This response to
naloxone is suggestive that the opiate was responsible
for the eye movement defect, although no opiate receptor
sites have yet been identified in the region of the medial
longitudinal fasciculus. The bilateral INO returned about
3 hours later but resolved completely by day 4 following
presentation.
Stroke has been reported as a sequela of heroin use;
however, no reports were found which specifically
included ocular defects.
Nystagmus
Downbeat nystagmus has been observed after intra-
venous injection of opioids (100 mg pethidine or 0.1 mg
fetanyl).81 Mild cerebellar syndrome developed with
ataxia, dysarthria and intention tremor. Similar effects
occurred from both drugs, and have been reported
previously with methadone. The mechanism may be
related to the presence of opioid receptors in the
cerebellum.
Injury from self-abuse
Self-injury was suspected in a supposed former heroin
addict, now using methadone and barbituates.82 The
24-year-old woman presented with a left hyphaema.
Once the hyphaema had cleared a needle track was seen
through the lens and vitreous to a rent in the retina.
Perforating corneal scars were also present. The injury
may not always be intentional. Hawkins et al.83 report
Horner’s syndrome in a user following injection into the
neck area and presumed damage of the sympathetic
fibres (neck or groin area was used for injection as the
arms were no longer able to be used).
Prenatal exposure
A higher number of strabismic children are born to
heroin/methadone-dependent women than in the normal
population.84,85 Of 29 infants born to mothers at a
methadone hydrochloride maintenance programme
centre, 7 developed strabismus.84 Four esotropic cases
had a mean age at diagnosis of 10.5 months (range 6–12
months) and 3 exotropic cases had mean age at diagnosis
of 15 months (range 6–27 months). The babies who
developed strabismus showed a lower birth weight and
their mothers had higher use during pregnancy of other
drugs (e.g. antidepressants). There were no other
differences in aspects studied (e.g. Apgar score, size,
head circumference). Dominguez et al.39 (as above)
reported one heroin-exposed baby who had exotropia,
and global delay with truncal ataxia and hypertonicity.
Changes in eye movement systems
Studies have been inconclusive regarding fixations
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during reading86 and tracking accuracy,87 due to poor
control of studies. Rothenberg et al. measured saccadic88
and smooth pursuit89 movements in a group of adults
who were not drug-abusers after administration of 10 mg
of oral methadone. The gain in smooth pursuit was
reduced and an undershoot of saccades occurred which
increased with increasing horizontal displacement of the
target. The latency from target displacement to initiation
of saccade was retarded. The authors suggested that the
opiate binding sites identified in the area of the superior
colliculus may have a role in causing the changes in the
saccades. They point out that their findings were similar
to those reported by others where lesions had been
created in this area in animal models.
Defects in colour vision
Colour vision was found to be reduced in the blue–
purple range in heroin addicts compared with controls.
The level of defect (scored on the Farnsworth-Munsell
100-hue test) did not correlate with how the heroin was
used (inhalation or intravenously). No macular lesions
were found in the users and the pathogenesis was not
explained; the defect could be retinal or within the visual
pathway.90
Hallucinogenics
LSD (lysergic acid diethylamide)
LSD is a mood-altering drug which alters the state of
perception and produces hallucinations and illusions that
may be visual, auditory, related to the body or time.
Visual changes include91 blurring of vision (LSD dilates
the pupils), imagery of patterns, fog, smoke which fills
the visual field, changes in faces or body parts, changes
in size and shape of objects/image distortion, heightened
colours, false perception of movement, and trailing
phenomena (i.e. discontinuous stationary images that
trail behind the moving object).92 LSD users may also
experience hallucinogen persisting perception disorder
(HPPD), that is either flash-backs or longer-lasting
alterations of perceptions, after use of LSD.93 Woody94
reports 3 subjects, all of whom had used LSD along with
other drugs (from amongst cannabis, heroin, ampheta-
mines), who each reported a visual hallucination or
prolonged after-image whilst driving. Physiological
nystagmus has been shown to increase in frequency
and amplitude after oral administation of 120 g of
LSD.95 Sun-gazing whilst under the influence of LSD,
leading to solar retinopathy, has been reported.96–98
Palinopsia
Kawasaki and Purvin99 report palinopsia (the visual
preservation of a recently seen object, usually associated
with infarction, tumour, trauma or arteriovenous mal-
formation) during acute LSD intoxication in 3 patients,
each of whom also suffered the effect following
discontinuation of the drug. The palinopic images were
of a complementary colour in 2 patients and consisted of
a trailing image in the third. All showed a normal
neurological examination. The mechanism is not fully
understood but failure of inhibition in an activated visual
circuit can be considered.
Accommodative convergence/accommodation (AC/A)
ratio
Payne100 measured the AC/A ratio by a gradient method
before and after varying doses of LSD in 10 male
healthy volunteers. Mydriasis was noted in all subjects.
The mean AC/A ratio increased from 4.83 0.844 to
6.08 0.973 ( p0.01) but the change was not related to
dose. The authors interpret this as due to a cycloplegic
effect of the LSD, but were not able to determine
whether this was due to sympathomimetic or parasym-
patholytic effects of the drug.
Ecstasy (methylenedioxymethamphetamine: MDMA)
MDMA acts by increasing the net release of the
monoamine neurotransmitters (mainly serotonin and
noradrenaline, with increased release of dopamine to a
lesser extent).101 Adverse reactions include: headache,
loss of appetite, dry mouth, muscular tension, hyperther-
mia, cerebral oedema, hepatopathy, tachycardia, hyper-
tension, and intracerebral haemorrhage (frequently
related to an underlying vascular malformation such as
aneurysm or arteriovenous malformation102).
One common complaint during use is blurred
vision.101 The mechanism for this is not stated but
visual disturbances are a side effect of amphetamines
and the blurred vision may arise from the increase in
noradrenaline causing a dilated pupil or affecting
accommodation. Two of 37 cases reported to the Poisons
Information Centre in Ireland over an 18 month period
were reported to have dilated pupils;103 no other ocular
symptoms were reported in this group.
Flashbacks have also been reported in two ecstasy
users, one of whom had occasionally used LSD in the
past.104
Ocular motility problems
One case of bilateral sixth nerve palsy has been reported
in a 17-year-old man who had been taking ecstasy tablets
(80–160 mg) at 5 to 7 day intervals over a period of 2
months.105 Diplopia occurred approximately 24 hours
after taking two tablets and resolved within 5 days.
Abduction was mildly limited and a deviation of 10
was present in the primary position increasing to 15 on
right and left gaze. In addition minimal paresthesia was
present in both arms and legs and there was mild
sleepiness. All neurological investigations were normal,
and there were no other signs of central nervous system
or neurodegenerative disease. The mechanism for the
sixth nerve involvement is speculative but the authors
propose either a mild cerebral oedema not detectable by
magnetic resonance imaging or interaction of MDMA
with serotonin metabolism in the sixth nerve, if
serotoninergic interneuronal fibres exist in humans as
found in the cat.
Visual acuity loss
Sudden loss of vision due to a retinal haemorrhage has
been reported in a 22-year-old woman 30 minutes after
taking an ecstasy tablet.106 Examination revealed visual
acuity of 1/60 in the affected eye with a subinternal
limiting membrane haemorrhage at the centre of the left
macula with retrohyaloid haemorrhages above and
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below the macula. No other abnormalities were found
and 3 months later the visual acuity was 6/9 and the
haemorrhages had resolved. The cause is suggested to be
a sudden rise in blood pressure affecting the retinal
circulation, which is vulnerable to sudden changes in
blood pressure.
Visual perception disorder
Destruction of serotonergic nerve terminals has been
suggested as the mechanism for a persistent visual
perception disorder in a 22-year-old man with a 3 year
history of drug abuse.107 The patient reported ‘hundreds
of transparent dots moving chaotically over his whole
visual field’. The phenomenon increased in the dark, and
with his eyes closed small coloured dots were seen. This
patient had also used cannabis regularly and had used
LSD on between five and seven occasions.
Palinopsia
Palinopsia was reported in 2 patients in a series of 13
who presented with psychiatric problems.108 One had
previously used LSD on several occasions and had used
ecstasy on one occasion only. The other had not used any
other drugs.
Magic mushrooms
Common varieties of mushrooms used are Liberty Cap
(Psilocybe semilanceata) and Mexican mushroom (Psi-
locybe mexicana). The active ingredients in mushrooms
are psilocybin and psilocin. The effects are similar to
those of LSD, the main ones being psychological –
feeling euphoric, giggly and happy. The senses are
increased so that colours are more intense and music
sounds richer. Heart rate and blood pressure increase
slightly and the pupils dilate. At higher doses hallucina-
tions occur. Anxiety, fear and paranoia are less pleasant
effects. Malitz and Kanzler91 found the perceptual
distortions following administration of psilocybin in a
normal population to be similar to those of LSD (see
above), and similar changes in physiological nystagmus
to those produced by LSD have been reported.95 Fischer
et al.109 found contraction or closing in of nearby visual
space in a group of normal subjects under psilocybin.
Another mushroom used as a drug is the European Fly
Agaric (Amanita muscaria, which is poisonous when
uncooked), which contains a high concentration of
muscarine. Ocular side effects of its use are blurred
vision (due to reduced accommodation)110 and runny
eyes.
Mescaline
Mescaline is a hallucinogenic found in several types of
cactus that has effects similar to LSD. Whilst a liquid
form can be prepared it is usually available as a powder.
It is extremely rare in the UK. Malitz and Kanzler91
found that visual hallucinations occurred slightly more
frequently with mescaline than with LSD, although the
content of illusions was similar. Euphoria did not occur
with mescaline. Physiological nystagmus may in-
crease.95
Phencyclidine (PCP)
PCP is a stimulant with hallucinogenic properties. It is
bought in white crystalline powder form which may be
sniffed, smoked, swallowed or prepared for injection.
Mild hallucinations may occur and the user feels dreamy
and may experience distortions of time and space.
Amaurosis fugax
One case has been reported of amaurosis fugax asso-
ciated with PCP inhalation.111 The 45-year-old diabetic
man with hypertension and a history of coronary artery
disease presented with two episodes of sudden, transient
right vision loss in 3 days. The visual loss had occurred
6–8 hours after smoking an unknown substance. Urine
toxicology was positive for PCP. Fundoscopy was
normal and no retinal pallor seen.
Nystagmus
Liden et al.112 reported nystagmus in 5 of 9 cases of PCP
poisoning: 1 horizontal, 3 horizontal and vertical, and 1
horizontal, vertical and rotary. No further detail is given.
Miotic pupils were also listed as a sign. Herskowitz and
Oppenheimer113 suggest that nystagmus is an important
sign in distinguishing PCP poisoning from other drug
intoxications. In their two teenage cases ‘striking bursts
of irregular, shuddery, jerky nystagmus in the direction
of gaze’ were present, with the amplitudes being greatest
on upgaze. General signs were red cheeks, inflamed
nasal mucosae, dry tongue, increased lacrimation and
marked ataxia on walking. In another report 7 patients
admitted to an intensive care unit for PCP intoxication
all showed nystagmus, along with disorientation, delu-
sions and disorganised thoughts. The focus of the paper
was on use of physostigmine as an antidote and the
nystagmus did reduce following injections of this
drug.114
Method of literature review
Relevant articles were identified by a MEDLINE search
(1966 to June 2003) using the combined search terms
visual acuity, blindness, retinal haemorrhage, vision
disorders, eye diseases, diplopia, strabismus, eye move-
ments, ocular motility disorders, and the individual terms
cocaine and crack cocaine, MDMA (ecstasy), heroin and
heroin dependence, LSD, psilocybin and psilocin (magic
mushrooms), mescaline, phencyclidine. The search was
limited to human. Additionally, articles of relevance,
from peer-reviewed journals, that were referenced in the
articles identified from the MEDLINE search have been
included.
Conclusion
The main problems following use of class A drugs that
may present to the ophthalmologist or orthoptist include
cerebrovascular disease, retinal or corneal problems,
strabismus and ocular motility defects. Clinical exam-
ination will reveal the condition present but illicit drug
use should be considered in the differential diagnosis
where the aetiology is obscure or unexplained.
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